Total Funding
22
56
Total FundingVenture - Series Unknown raised
Growth Score 22 in past quarter
-6 pts
Heat Score 56 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68089
Emerge Diagnostics provides a tech-forward electrodiagnostic functional assessment solution.
Phil Reaston: Chief Technology Officer and FounderPast Role: IBM Consulting, Consulting IT Architect
Robert D. Thompson: ChairmanPast Role: eScreen, President and Chief Executive Officer
About the Company
Emerge Diagnostics is a California-based company focused on better management of musculoskeletal disorders with twin goals of better patient outcomes and reduced costs. The company's FDA-registered, the class-II diagnostic device is called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish
between acute versus chronic injury, and objectively quantify effort, enabling physicians to get better diagnoses and save healthcare costs.
The company was founded in 2012 and is headquartered in Carlsbad, California.
Women Founded